Medroxyprogesterone for Inducing Menstruation in Women with Amenorrhea

Patient Selection and Treatment

• Medroxyprogesterone acetate is appropriate for women with secondary amenorrhea where pregnancy has been ruled out 1
• If no withdrawal bleeding occurs after treatment, further evaluation for other causes of amenorrhea is warranted 1

Special Considerations

• Prolonged amenorrhea following DMPA is well-documented, with return to fertility typically taking 9-18 months after discontinuation 1
• If amenorrhea persists beyond 18 months after DMPA discontinuation, further evaluation is warranted 1

Alternative Approaches

• For women who do not respond to medroxyprogesterone or find it unacceptable, other contraceptive methods should be discussed 2 3
• Combined hormonal contraceptives may be considered as an alternative for inducing menstruation in women with amenorrhea 2
• Intrauterine devices (IUDs) are another option, with progesterone-eluting IUDs potentially beneficial for some patients 4

Common Pitfalls to Avoid

• Failing to rule out pregnancy before initiating treatment 1
• Not considering underlying pathologies such as thyroid dysfunction, hyperprolactinemia, or polycystic ovary syndrome 1
• Assuming amenorrhea is solely due to hormonal imbalance without proper evaluation, especially when it persists despite treatment 1
• Not addressing patient concerns about fertility if pregnancy is desired 1

Long-term Considerations

• If amenorrhea persists and the woman finds it unacceptable, counseling on alternative contraceptive methods should be provided 3